PropertyValue
?:abstract
  • We would like to share ideas on the report on \'Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials [1].\'Balevic noted that \'well-designed clinical trials that include patients with rheumatic disease are urgently needed to characterize the efficacy, safety, and target exposures for hydroxychloroquine [1].\'
?:creator
?:doi
?:doi
  • 10.3899/jrheum.200638
?:journal
  • The_Journal_of_rheumatology
?:license
  • unk
?:pmid
?:pmid
  • 32451353.0
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Evidence of protective effect of hydroxychloroquine to prevent COVID-19.
?:type
?:year
  • 2020-05-25

Metadata

Anon_0  
expand all